Publication | Closed Access

Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy

NanomedicinePolymer-drug ConjugateImmunologyImmune Checkpoint InhibitorTumor TargetingFeasible Delivery PlatformImmunotherapyMedicineRadiation OncologyPhenylboronic-acid-based NanocomplexTumor Microenvironment